Scientists Advance Prospects for Permanently Putting AIDS Virus into Dormant State Using Gene Therapy
Read Full ArticleLatest News
-
09/19/2025
Scientists Find Potential New Drug Target for Psychiatric and Neurological Disorders
-
09/16/2025
New Brain Shunt Surgery Trial Restores Walking and Independence in Older Adults with iNPH
-
09/15/2025
World Patient Safety Day: Johns Hopkins Experts Available for Interviews on Improving Pediatric Care
Contact Johns Hopkins Media Relations
Johns Hopkins Medicine In the News
-
Hand, foot, and mouth disease 101
Fox 5 (D.C.)
Dr. Emily Boss, director of pediatric otolaryngology, Johns Hopkins Children's Center, discusses the common viral illness hand, foot, and mouth disease. -
This new MS drug could change everything
WebMD
The new drug, called tolebrutinib, is designed to penetrate the brain and spinal cord, targeting the way MS damages the nervous system, not just the inflammatory flare-ups. "It's really exciting," says Michael D. Kornberg, MD, PhD, a neurologist at Johns Hopkins University School of Medicine.